What is PharmaCorp Rx Inc.'s (PCRX.V) StockRank?

MoatMap's StockRank for PharmaCorp Rx Inc. (PCRX.V) is 54/100, with a Hold signal. This is a composite score combining Quality (49), Value (34), and Momentum (61) factor ranks across MoatMap's 20,000+ stock universe.

Does PharmaCorp Rx Inc. have an economic moat?

PharmaCorp Rx Inc. (PCRX.V) has a Quality factor score of 49/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is PharmaCorp Rx Inc. a buy, hold, or sell?

MoatMap's current signal for PharmaCorp Rx Inc. (PCRX.V) is Hold, based on a StockRank of 54/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is PharmaCorp Rx Inc. in?

PharmaCorp Rx Inc. (PCRX.V) operates in the Healthcare sector, specifically the Pharmaceutical Retailers industry (Canada).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

PCRX.V

HOLDREMOVE

PharmaCorp Rx Inc. · Healthcare · Canada · $65M · Avg Vol: $37K/d

StockRank

P/E (TTM)

—

ROE

-3.7%

D/E

0.1x

Dividend %

—

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

PharmaCorp Rx is a micro-cap Canadian pharmacy services provider. It lacks the scale, liquidity, and global thematic tailwinds required for a concentrated institutional portfolio.

COMPANY DESCRIPTION

PharmaCorp Rx Inc. operates as a pharmaceutical retailer and pharmacy services provider in Canada, focusing on acquiring and operating independent pharmacies. The company's business model leverages centralized administrative support and bulk purchasing power to improve operating margins for its network of community pharmacies. It positions itself as a stable, cash-generating consolidator in the highly resilient Canadian healthcare retail sector.

FINANCIAL SUMMARY (USD)

Year	2022	2023	2024	2025	CAGR
Revenue	0	0	4.1M	14.7M	260.6%
EPS	-0.00	-0.00	-0.01	—	—
Shares	174.1M	174.1M	117.3M	174.1M	0.0%
Debt	11,620	0	0.7M	3.2M	551.1%
Equity	1.9M	1.6M	21.4M	36.6M	167.4%
Op CF	-84,818	-0.4M	88,195	1.4M	1505.5%
Inv CF	—	0	-11.9M	-9.7M	—
Fin CF	1.3M	19,648	19.3M	17.4M	—

PRICE (1Y)+9.5%

SMA 50SMA 200

$0.37

RSI (14)

70.0

52W High

$0.39

From 52W High

0.9%

SCORE BREAKDOWN

Quality

ROIC

-1.2%42.9

ROE

-3.7%40.5

GP/Assets

14.2%33.7

Op. Margin

-0.7%35.0

FCF/Assets

-1.6%44.9

Piotroski

549.3

Int. Cover

-7.4x25.8

D/E Ratio

0.08x68.0

Current Ratio

9.42x86.0

Value

P/E (TTM)

—N/A

EV/EBITDA

-119.5x25.0

P/FCF

—N/A

P/B

1.7x66.4

P/S

3.6x50.4

Div Yield

—N/A

Momentum

52W High %

95%89.6

RS 6M

7%78.3

SMA 50/200

1.06x73.8

EPS Rev 4W

-12.3%4.3

EPS Rev 12W

—N/A

EPS Improve

—N/A

Q Growth

-55%8.5

FUNDAMENTALS

Market Cap

$65M

P/E (Forward)

18.7x

Gross Margin

39.3%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of PCRX.V are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
PCRX.V	PharmaCorp Rx Inc.(you)	$65M	54	HOLD
HITI.V	High Tide Inc.	$203M	30	SELL
VST.CN	Victory Square Technologies Inc.	$51M	55	HOLD
DB.V	Decibel Cannabis Company Inc.	$50M	60	HOLD
HLS.TO	HLS Therapeutics Inc.	$100M	63	HOLD
TELI.CN	Telescope Innovations Corp.	$49M	40	HOLD
NVRS.CN	Noveris Health Sciences Inc.	$64M	23	SELL
LEEF.CN	Leef Brands Inc.	$46M	29	SELL
OGI.TO	Organigram Global Inc.	$138M	33	SELL
EDSA	Edesa Biotech, Inc.	$61M	17	STRONG SELL

Peer medians: ROE -46.6% · P/E 14.3x · Gross margin 32.9%

PharmaCorp Rx Inc. (PCRX.V) — Stock Score Summary

PharmaCorp Rx Inc. (PCRX.V) has a MoatMap StockRank of 54/100 based on Quality (49/100), Value (34/100), and Momentum (61/100) factor scores. The current signal is HOLD. PharmaCorp Rx is a micro-cap Canadian pharmacy services provider. It lacks the scale, liquidity, and global thematic tailwinds required for a concentrated institutional portfolio.

Key Financial Metrics

Price	$0.37
Market Cap	$65M
P/E (Forward)	18.75
Price/Book	1.66
Return on Equity	-3.7%
Return on Invested Capital	-1.2%
Debt/Equity	8.47
Gross Margin	39.3%
Operating Margin	-0.7%
Revenue Growth	79.4%
Free Cash Flow	$-782K

PharmaCorp Rx Inc. operates in the Pharmaceutical Retailers industry, part of the Healthcare sector (Canada).

Frequently Asked Questions

What is PharmaCorp Rx Inc.’s (PCRX.V) StockRank?: MoatMap’s StockRank for PharmaCorp Rx Inc. (PCRX.V) is 54/100, with a Hold signal. It is a composite of Quality (49), Value (34), and Momentum (61) factor ranks across MoatMap’s 20,000+ stock universe.
Does PharmaCorp Rx Inc. have an economic moat?: PharmaCorp Rx Inc. (PCRX.V) has a Quality factor score of 49/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is PharmaCorp Rx Inc. a buy, hold, or sell?: MoatMap’s current signal for PharmaCorp Rx Inc. (PCRX.V) is Hold, based on a StockRank of 54/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is PharmaCorp Rx Inc. in?: PharmaCorp Rx Inc. (PCRX.V) operates in the Healthcare sector, specifically the Pharmaceutical Retailers industry (Canada).